Reduced diversity and imbalance of fecal microbiota in patients with ulcerative colitis (Q44544446)

4 December 2017

title

Reduced diversity and imbalance of fecal microbiota in patients with ulcerative colitis (English)

1 reference

4 December 2017

1 reference

Hideyuki Nemoto

1

1 reference

4 December 2017

Keiko Kataoka

2

1 reference

4 December 2017

Hideki Ishikawa

3

1 reference

4 December 2017

Kazue Ikata

4

1 reference

4 December 2017

Hideki Arimochi

5

1 reference

4 December 2017

Teruaki Iwasaki

6

1 reference

4 December 2017

Yoshinari Ohnishi

7

1 reference

4 December 2017

Tomomi Kuwahara

8

1 reference

4 December 2017

Koji Yasutomo

9

1 reference

4 December 2017

publication date

24 May 2012

1 reference

Digestive Diseases and Sciences

4 December 2017

published in

1 reference

4 December 2017

volume

57

1 reference

4 December 2017

issue

11

1 reference

4 December 2017

page(s)

2955-2964

1 reference

Prevalence of ulcerative colitis and Crohn's disease in Japan.

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2236-Y

Interleukin-10-deficient mice develop chronic enterocolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2236-Y

Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2236-Y

Mucosa-associated bacteria in ulcerative colitis before and after antibiotic combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2236-Y

Intestinal TM7 bacterial phylogenies in active inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2236-Y

Sulphate-reducing bacteria and hydrogen sulphide in the aetiology of ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2236-Y

A genome-wide association study identifies three new susceptibility loci for ulcerative colitis in the Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2236-Y

Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2236-Y

Psychological stress in IBD: new insights into pathogenic and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2236-Y

Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2236-Y

Bacteroides vulgatus protects against Escherichia coli-induced colitis in gnotobiotic interleukin-2-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2236-Y

Characterization of antibody responses against rectal mucosa-associated bacterial flora in patients with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2236-Y

Hydrogen sulphide: a bacterial toxin in ulcerative colitis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2236-Y

Towards the human intestinal microbiota phylogenetic core

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2236-Y

The human intestinal microbiome: a new frontier of human biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2236-Y

Rationale for the luminal provision of butyrate in intestinal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2236-Y

Review article: the role of butyrate on colonic function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2236-Y

Commensal host-bacterial relationships in the gut

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2236-Y

Differential effects of short-chain fatty acids on proliferation and production of pro- and anti-inflammatory cytokines by cultured lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2236-Y

The gut microbiota shapes intestinal immune responses during health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2236-Y

Immune adaptations that maintain homeostasis with the intestinal microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2236-Y

Cyclosporine in severe ulcerative colitis refractory to steroid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2236-Y

Development of 16S rRNA-gene-targeted group-specific primers for the detection and identification of predominant bacteria in human feces

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2236-Y

Identification and quantitation of mucosal and faecal desulfovibrios using real time polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2236-Y

Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2236-Y

Real-time PCR quantitation of clostridia in feces of autistic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2236-Y

Development of Bacteroides 16S rRNA gene TaqMan-based real-time PCR assays for estimation of total, human, and bovine fecal pollution in water

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2236-Y

On the action of 5-amino-salicylic acid and sulfapyridine on M. avium including subspecies paratuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2236-Y

Coordination of tolerogenic immune responses by the commensal microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2236-Y

Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2236-Y

Diversity of mucosa-associated microbiota in active and inactive ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2236-Y

Unstable composition of the fecal microbiota in ulcerative colitis during clinical remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2236-Y

On the action of cyclosporine A, rapamycin and tacrolimus on M. avium including subspecies paratuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2236-Y

In vitro activity of ramoplanin and comparator drugs against anaerobic intestinal bacteria from the perspective of potential utility in pathology involving bowel flora

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2236-Y

Enterococcus faecalis strains differentially regulate Alix/AIP1 protein expression and ERK 1/2 activation in intestinal epithelial cells in the context of chronic experimental colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2236-Y

Enterococcus faecalis induces inflammatory bowel disease in interleukin-10 knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2236-Y

Randomized controlled trial of the effect of bifidobacteria-fermented milk on ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2236-Y

Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2236-Y

Randomized placebo-controlled trial assessing the effect of bifidobacteria-fermented milk on active ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2236-Y

The contribution of sulphate reducing bacteria and 5-aminosalicylic acid to faecal sulphide in patients with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2236-Y

Understanding the effects of diet on bacterial metabolism in the large intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2236-Y

Microbes in gastrointestinal health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2236-Y

Lactate is mainly fermented to butyrate by human intestinal microfloras but inter-individual variation is evident

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2236-Y

Imbalance in intestinal microflora constitution could be involved in the pathogenesis of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2236-Y

Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2236-Y

Influence of dietary protein supplements on the formation of bacterial metabolites in the colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2236-Y

Effects of amino acid-derived luminal metabolites on the colonic epithelium and physiopathological consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2236-Y

Treatment of ulcerative colitis using fecal bacteriotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2236-Y

Terminal restriction fragment length polymorphism analysis of the diversity of fecal microbiota in patients with ulcerative colitis

21 January 2018

1 reference

12 December 2020

Rapid and Noninvasive Metabonomic Characterization of Inflammatory Bowel Disease

1 reference

12 December 2020

Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut.

1 reference

12 December 2020

Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea

1 reference

12 December 2020

Terminal restriction fragment length polymorphism analysis for human fecal microbiota and its application for analysis of complex bifidobacterial communities

1 reference

12 December 2020

Improved methodology of qualitative and quantitative analysis of the intestinal flora of man and animals

1 reference

12 December 2020

Effects of fermented brown rice on the intestinal environments in healthy adult

1 reference

12 December 2020

Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides

1 reference

12 December 2020

Fusobacterium varium localized in the colonic mucosa of patients with ulcerative colitis stimulates species-specific antibody

1 reference

12 December 2020

10.1007/S10620-012-2236-Y

Identifiers

DOI

1 reference

4 December 2017

1 reference